Harriet E. Gee - Concepedia

Author

Harriet E. Gee

University of Oxford ORCID

Also Known As

Gee, Harriet E., Gee, Harry, H E Gee, H Gee, H. GEE, H. Gee, H. Knowles, H.E. Gee, Harriet E Gee, Harriet E. Gee

119

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of Oxford The University of Sydney John Radcliffe Hospital Chris O’Brien Lifehouse Centre for Human Genetics

About

Harriet E. Gee is an author at University of Oxford specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	719
2	Engineering	1	1	310
3	Nursing	1	1	287
4	Public Health	1	1	287
5	Allergy	1	1	18

Harriet E. Gee

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU Elena Favaro, Anassuya Ramachandran, Robert McCormick, PLoS ONE	2010	331
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer Francesca M. Buffa, Laura Winchester, Cameron Snell, Cancer Research Breast OncologyEngineeringPathologyGene Expression ProfilingTumor Biology	2011	310
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis Harriet E. Gee, Francesca M. Buffa, Carlos Camps, British Journal of Cancer	2011	288
Effects of redesigned community postnatal care on womens' health 4 months after birth: a cluster randomised controlled trial Christine MacArthur, HR Winter, Charles H. Knowles, The Lancet NursingFamily MedicineCommunity Postnatal CarePrimary CarePregnancy	2002	287
hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer Harriet E. Gee, Carme Camps, Francesca M. Buffa, Cancer	2010	243
Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome Rhiannon K. Beckers, Christina Selinger, Ricardo E. Vilain, Histopathology	2015	236
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense Marina Pajic, Danielle Froio, Sheridan Daly, Cancer Research	2017	128
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts Krishan Kumar, Simon Wigfield, Harriet E. Gee, Journal of Molecular Medicine Hypoxic AdaptationOncogenic AgentMedicineTherapeutic EfficacyImmune Checkpoint Inhibitor	2013	72
Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers Xiaoying Zhang, Harriet E. Gee, Barbara Rose, BMC Cancer	2016	63
<i>In vivo</i> dosimetric impact of breast tissue expanders on post‐mastectomy radiotherapy Harriet E. Gee, Fiona Bignell, David Odgers, Journal of Medical Imaging and Radiation Oncology	2015	34

Page 1